Stay updated on Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.

Latest updates to the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check17 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.7%

- Check24 days agoChange DetectedThe site footer’s revision label changed from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check38 days agoChange DetectedThe record history now includes additional change categories (Study Design, Study Status, Study Identification, and Recruitment Status). The older recruitment status value 'Active, not recruiting' was removed.SummaryDifference0.8%

- Check52 days agoChange DetectedA new revision label 'Revision: v3.7.0' appears in the history, and the previous 'Revision: v3.6.6' entry is removed, indicating a software/version update on the page.SummaryDifference0.1%

Stay in the know with updates to Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teplizumab in Pediatric Stage 2 Type 1 Diabetes Clinical Trial page.